Easy to read patient leaflet for delavirdine. Includes indications, proper use, special instructions, precautions, and possible side effects.
Delavirdine (DLV) (brand name Rescriptor) is a non-nucleoside reverse transcriptase inhibitor (NNRTI) marketed by ViiV Healthcare. It is used as part of highly active ...
Delavirdine (Rescriptor) is a drug prescribed along with other anti-HIV drugs to treat HIV infection. Several drugs interact with delavirdine and there are several ...
What is delavirdine? Delavirdine is a prescription medicine approved by the U.S. Food and Drug Administration (FDA) for the treatment of HIV infection in adults.
Several FDA-approved drug labels may be available for delavirdine. AIDSinfo provides the following drug label solely as an example of the labels available for ...
Find patient medical information for delavirdine oral on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings.
delavirdine [del″ah-vir´dēn] an antiretroviral agent, that acts as a non-nucleoside reverse transcriptase inhibitor; administered orally as the mesylate salt in ...
Delavirdine is used, in combination with other medicines, in the treatment of the infection caused by the human immunodeficiency virus (HIV). HIV is the ...
Delavirdine comes as a tablet to take by mouth. It usually is taken three times a day with or without food. Take delavirdine around the same times every day.
Rescriptor official prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions, pharmacology and more.